PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

198.40p
   
  • Change Today:
    -10.60p
  • 52 Week High: 237.50
  • 52 Week Low: 140.40
  • Currency: UK Pounds
  • Shares Issued: 270.81m
  • Volume: 650,542
  • Market Cap: £537.30m

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Key Personnel

CEO: Bharatt Chowrira
Chairman: Raju Kucherlapati
Independent Non-Executive Director: Sharon Barber-Lui
Independent Non-Executive Director: John LaMattina
Independent Non-Executive Director: Kiran Mazumdar Shaw
Non-Executive Dir: H. Robert Horvitz, Robert Langer

Contact Details

Address: 8th Floor, 20 Farringdon Street, London, United Kingdom, EC4A 4AB
Website: http://www.puretechhealth.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
Overseas Listings: BATSLON:PRTCL
ISIN: GB00BY2Z0H74

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 198.40p
Change Today -10.60p
% Change -5.07 %
52 Week High 237.50
52 Week Low 140.40
Volume 650,542
Shares Issued 270.81m
Market Cap £537.30m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.02% below the market average16.02% below the market average16.02% below the market average16.02% below the market average16.02% below the market average
37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average
Price Trend
27.66% above the market average27.66% above the market average27.66% above the market average27.66% above the market average27.66% above the market average
58.49% above the sector average58.49% above the sector average58.49% above the sector average58.49% above the sector average58.49% above the sector average
Income Not Available
Growth
67.39% below the market average67.39% below the market average67.39% below the market average67.39% below the market average67.39% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 24-Jun-2024

Time Volume / Share Price
16:47 6,536 @ 200.30p
16:36 59,000 @ 201.52p
16:35 159,970 @ 198.40p
16:35 1,918 @ 198.40p
16:35 2,203 @ 198.40p

PRTC Key Personnel

Chair Raju Kucherlapati
CEO Bharatt Chowrira

Top of Page